HOMA-IR Calculator

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) estimates how much insulin your body is producing to keep fasting glucose in range. A higher HOMA-IR score means more insulin is being produced relative to the glucose level — the body is working harder to clear sugar from the bloodstream. The score is one of the earliest available signals of metabolic dysfunction, often shifting years before fasting glucose itself rises out of range.

HOMA-IR = (Fasting Insulin [μIU/mL] × Fasting Glucose [mg/dL]) / 405. The 405 divisor normalizes the result against the steady-state model assumed by the original Matthews et al. (1985) derivation. If glucose is entered in mmol/L, it is converted to mg/dL (multiplied by 18.018) before the calculation. Both values must be from the same fasting blood sample (8 to 12 hours, water only).

The LifeLedgerX optimal-targets framework uses stricter thresholds than many standard lab reference ranges: below 1.0 is Optimal; 1.0 to 1.9 is Healthy Range; 2.0 to 2.9 is Borderline Insulin Resistance; 3.0 and above is Significant Insulin Resistance. These targets reflect optimal metabolic health, not the population average. Many standard lab reports flag concern only above 2.5 or 3.0 — the LLX targets are tighter because the goal is metabolic optimization, not just avoiding clinical disease.

HOMA-IR is the more direct measure of insulin resistance when fasting insulin is available — it uses fasting insulin directly. The TyG Index Calculator is a surrogate that uses fasting triglycerides as a proxy when fasting insulin is not on the lab panel. Use HOMA-IR when you have insulin on your panel; use TyG when you do not, or to triangulate a HOMA-IR result with a second data point.

No. HOMA-IR is invalidated entirely by exogenous insulin therapy. The calculation assumes endogenous insulin only — that is, insulin produced by your own pancreas — because the homeostatic model breaks when an external insulin source is added. If you are on insulin therapy for diabetes management, HOMA-IR is not the right tool for assessing insulin sensitivity. Discuss alternative monitoring approaches with your healthcare provider.

Yes. Metformin reduces insulin resistance and will lower the calculated HOMA-IR — your unmedicated score would likely be higher. Corticosteroids (prednisone, dexamethasone) raise insulin resistance and can elevate HOMA-IR independent of your baseline. Some antipsychotics (olanzapine, clozapine) are associated with increased insulin resistance. The number still has meaning for tracking change over time, but a single HOMA-IR reading under treatment is not equivalent to an unmedicated reading.

HOMA-IR responds to the same interventions that improve insulin sensitivity broadly: reducing refined-carbohydrate intake, regular movement (resistance training plus Zone 2 cardio), consistent sleep (7-8 hours), and managing chronic stress. Lifestyle interventions typically move HOMA-IR meaningfully in 8 to 12 weeks. Pair tracking with the HbA1c Interpreter for a longer-window view of glucose regulation and the Lipid Panel & Ratios (TG:HDL) for the downstream cardiovascular picture.